| Sponsored by: L.E.K. Consulting | Published: February 9th
Confront the paradox of antibiotics pricing now. The need for effective antibiotics continues to grow but the pricing and reimbursement rates are too low to spur development of new treatments. We outline some aggressive steps to address this issue. Learn More.
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!